• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
  • For Subscribers
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 99 of 100
FDA rescinds ‘breakthrough’ status for Merck’s hepatitis C drug
Finance
FDA rescinds ‘breakthrough’ status for Merck’s hepatitis C drug
By Laura LorenzettiFebruary 4, 2015
Exclusive Look At Pharmaceuticals Manufacturing Inside Lupin Ltd. Facility, India's Third-Largest Drugmaker
Features
Is it time for the FDA to consider cost when it comes to new drugs?
By Laura LorenzettiFebruary 4, 2015
Inside of a Gilead Sciences Lab
Tech
Bigger drug discounts put question mark over Gilead’s stellar run
By Reuters and Fortune EditorsFebruary 4, 2015
Pharmacy technician Andrea Tibbetts counts out pills to fill an order for generic medications at Por
Finance
How to save on your prescription meds (yep, there’s an app for that)
By Jean ChatzkyFebruary 3, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Finance
After Allergan loss, is Valeant dumpster diving?
By Jen WiecznerJanuary 31, 2015
Key Speakers At Osons La France Economic Summit
Leadership
Fire in haste, repent at leisure: Sanofi wonders why it can’t find a new CEO
By ReutersJanuary 30, 2015
American Pharmaceutical Company Pfizer Propose To Takeover British AstraZeneca
Features
Pfizer’s outlook disappoints as it struggles with patent expirations
By Laura LorenzettiJanuary 27, 2015
Regeneron vaults ahead of Amgen in race to market cholesterol drug
Features
Regeneron vaults ahead of Amgen in race to market cholesterol drug
By ReutersJanuary 26, 2015
Negatively-stained Hong Kong Flu Virus
Features
One shot to cure them all: The quest for the universal flu shot
By Erika FryJanuary 21, 2015
Detroit auto show and Obama on cybersecurity — 5 things to know today
Features
Detroit auto show and Obama on cybersecurity — 5 things to know today
By Laura LorenzettiJanuary 12, 2015
Shire Plc's U.K. Offices As Drugmaker Rejects Abbvie Inc.'s $46.5 Billion Offer
Shire switches from target to predator with $5.2 billion NPS buy
By Geoffrey SmithJanuary 12, 2015
A powerful new super antibiotic may be right under our feet
Tech
A powerful new super antibiotic may be right under our feet
By Laura LorenzettiJanuary 8, 2015
Flu Outbreak Continues In Bay Area
Retail
It’s a bad flu season, but that’s good news for Walgreen
By Laura LorenzettiJanuary 6, 2015
Picture taken on January 15, 2012 in Lil
Features
The U.S. has a drug shortage — and people are dying
By Mark KobaJanuary 6, 2015
J&J starts clinical trials of Ebola drug
J&J starts clinical trials of Ebola drug
By ReutersJanuary 6, 2015
1...
  • 96
  • 97
  • 98
  • 99
  • 100
100
Most Popular
Personal Finance
Social Security has less than 6 years before a 22% cut. A Senate chairman’s fix is to borrow $190 trillion and call it the ‘Stop Scaring Seniors Act’placeholder alt text
By Nick LichtenbergNovember 19, 2026
Big Tech
Sound Ventures turned $435 million into a $7 billion Anthropic stake. Ashton Kutcher left months before the IPOplaceholder alt text
By Steven JohnNovember 19, 2026
Cybersecurity
‘This, I’m sorry to say, is just the opening chapter’: Top cyber expert warns of a ‘vulnpocalypse’ after 4 major U.S. systems broke in 6 daysplaceholder alt text
By Nick LichtenbergNovember 18, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.